Last reviewed · How we verify
NCT05296213
Medical Treatment of Early-Enamel Carious Lesion Using Different Remeneralizing Agents
NA trial testing Silver diamine fluoride- potassium iodide in Enamel Caries in 45 participants. Completed in 10 January 2022.
10 December 2021
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 1 December 2019 |
| Primary completion | 10 December 2021 |
| Estimated completion | 10 January 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Silver diamine fluoride- potassium iodide — full drug profile →
- Casein phosphopeptide amorphous calcium phosphate
- experimental tricalcium silicate — full drug profile →
Conditions studied
- Enamel Caries — all drugs for Enamel Caries →
Sponsor
Mansoura University
Who can join
Adults 15 to 50, any sex, with Enamel Caries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Medical Treatment of Early-Enamel Carious Lesion using Different Remeneralizing agents
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05296213
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Silver diamine fluoride- potassium iodide
Trials testing the same drug.
- NCT06797882 — Preventive Effects of Silver Diamine Fluoride on Early Enamel Caries · Phase 2 · not yet recruiting
- NCT06699199 — Effect of Silver Diamine Fluoride Application on Oral Microbiome of Healthy Pediatric Patient · Phase 4 · recruiting
- NCT07085689 — Evaluation of the Effectiveness of Various Desensitizing Treatment Protocols · NA · completed
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05296213 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 5 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05296213.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing